Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

May 2022; Volume 42,Issue 5

Reviews

  • Open Access
    Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions
    TOLGA SURSAL, JENNIFER S. RONECKER, ALIS J. DICPINIGAITIS, AVINASH L. MOHAN, MICHAEL E. TOBIAS, CHIRAG D. GANDHI and MEENA JHANWAR-UNIYAL
    Anticancer Research May 2022, 42 (5) 2225-2239; DOI: https://doi.org/10.21873/anticanres.15703
  • Open Access
    Radiotherapy and Immunotherapy: The Power of the Teamwork for the Treatment of NSCLC
    MARIA BASSANELLI, SARA RAMELLA, MASSIMO ZEULI and ANNA CERIBELLI
    Anticancer Research May 2022, 42 (5) 2241-2247; DOI: https://doi.org/10.21873/anticanres.15704
  • Open Access
    Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance
    EDOARDO VIRGILIO, FILIPPO MONTALI, ALFREDO ANNICCHIARICO, CARLO SALVEMINI, MANUEL BALDINU, ENRICO GIARNIERI, MONICA MONTAGNINI, SANDRA VILLANI, ANTONELLA PROIETTI, ROSARIA D’URSO and RENATO COSTI
    Anticancer Research May 2022, 42 (5) 2249-2259; DOI: https://doi.org/10.21873/anticanres.15705
  • Open Access
    The Implication of X-Linked Genetic Polymorphisms in Susceptibility and Sexual Dimorphism of Cancer
    CHAROULA ACHILLA, THEODOSIOS PAPAVRAMIDIS, LEFTERIS ANGELIS and ANTHOULA CHATZIKYRIAKIDOU
    Anticancer Research May 2022, 42 (5) 2261-2276; DOI: https://doi.org/10.21873/anticanres.15706

Experimental Studies

  • Open Access
    The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer
    MIN HAN, SHIGEO YAMAGUCHI, MAI ONISHI, TOMOAKI FUJII, MASAKI HOSOYA, XUAN WEN, HIDENORI KIDO and SHUNSUKE KATO
    Anticancer Research May 2022, 42 (5) 2277-2288; DOI: https://doi.org/10.21873/anticanres.15707
  • Open Access
    Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer
    RAIMONDA KLIMAITE, MINTAUTE KAZOKAITE, AISTE KONDROTIENE, DALIA DAUKSIENE, RASA VERKAUSKIENE, BIRUTE ZILAITIENE and ALBERTAS DAUKSA
    Anticancer Research May 2022, 42 (5) 2289-2299; DOI: https://doi.org/10.21873/anticanres.15708
  • Open Access
    Dimethyl Fumarate Induces Apoptosis via Inhibiting NF-κB and STAT3 Signaling in Adult T-cell Leukemia/Lymphoma Cells
    TAKAHIRO MAETA, TSUYOSHI SATO, KAZUYA ASANO and SHIGEKI ITO
    Anticancer Research May 2022, 42 (5) 2301-2309; DOI: https://doi.org/10.21873/anticanres.15709
  • Open Access
    Pathological Significance and Prognostic Role of WWC1 in Upper Urinary Tract Urothelial Cancer
    HIROKI KURATA, KENSUKE MITSUNARI, TSUBASA KONDO, MASAHITO MASATO, HIDENORI ITO, YUTA MUKAE, YUICHIRO NAKAMURA, TOMOHIRO MATSUO, KOJIRO OHBA, YASUSHI MOCHIZUKI, HIDEKI SAKAI and YASUYOSHI MIYATA
    Anticancer Research May 2022, 42 (5) 2311-2317; DOI: https://doi.org/10.21873/anticanres.15710
  • You have access
    Expression of ENO1 Is Up-regulated in Low-grade Glioma and Positively Correlated With Meningioma Grade
    DANG THUY DIEM DINH, SASKIA KUHL, LUKAS GÖRTZ, ROLAND GOLDBRUNNER and MARCO TIMMER
    Anticancer Research May 2022, 42 (5) 2319-2326; DOI: https://doi.org/10.21873/anticanres.15711
  • You have access
    ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors
    REINHARD E. FRIEDRICH, LOUISA K. N. NÖRNBERG and CHRISTIAN HAGEL
    Anticancer Research May 2022, 42 (5) 2327-2340; DOI: https://doi.org/10.21873/anticanres.15712
  • Open Access
    Guanylate-binding Protein 2 Expression Is Associated With Poor Survival and Malignancy in Clear-cell Renal Cell Carcinoma
    QINGYUAN LIU, ROBERT M. HOFFMAN, JING SONG, SHIQI MIAO, JINDONG ZHANG, DEGANG DING and DELIN WANG
    Anticancer Research May 2022, 42 (5) 2341-2354; DOI: https://doi.org/10.21873/anticanres.15713
  • You have access
    Investigating miRNA-related Pathways Contributing to Kidney Cancer Pathogenesis
    PETER YOUSEF, RANIA IBRAHIM, CARL BOULOS, ZIYAD KHATAB, MARIA PASIC and ADRIANA KRIZOVA
    Anticancer Research May 2022, 42 (5) 2355-2362; DOI: https://doi.org/10.21873/anticanres.15714
  • You have access
    Effectiveness of Hyperthermia as Monotherapy and Adjuvant Therapy Approaches Against an In Vitro Model of Colorectal Carcinoma
    GEORGIOS PETRAKIS, THEODORA MANTSO, MICHAIL I. KOUKOURAKIS, MIHALIS I. PANAYIOTIDIS and SOTIRIS BOTAITIS
    Anticancer Research May 2022, 42 (5) 2363-2374; DOI: https://doi.org/10.21873/anticanres.15715
  • Open Access
    Contribution of 5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase Genotypes to Colorectal Cancer in Taiwan
    MING-HSIEN WU, CHAO-HSUAN CHEN, CHOU-PIN CHEN, TAI-LIN HUANG, TE-CHENG YUEH, ZHI-HONG WANG, CHIA-WEN TSAI, JEN-SHENG PEI, MEI-CHIN MONG, YA-CHEN YANG, DA-TIAN BAU and WEN-SHIN CHANG
    Anticancer Research May 2022, 42 (5) 2375-2382; DOI: https://doi.org/10.21873/anticanres.15716
  • You have access
    Tumor-infiltrating ICOS+ Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and ‘Hot’ Tumor
    HITOMI KAJIKAWA, MICHINARI HIRATA, MIYA HARUNA, AZUMI UEYAMA, KATSUTOSHI HIROSE, ATSUNARI KAWASHIMA, KOTA IWAHORI, KAZUHIDE MATSUNAGA, SATORU TOYOSAWA, NARIKAZU UZAWA and HISASHI WADA
    Anticancer Research May 2022, 42 (5) 2383-2393; DOI: https://doi.org/10.21873/anticanres.15717
  • You have access
    Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success
    SHIMPEI EGUCHI, KENJIRO KIMURA, KEN KAGEYAMA, NAOKI TANI, RYOTA TANAKA, KOHEI NISHIO, HIROJI SHINKAWA, GO OHIRA, RYOSUKE AMANO, SHOGO TANAKA, AKIRA YAMAMOTO, SHIGEKAZU TAKEMURA, MASAKAZU YASHIRO and SHOJI KUBO
    Anticancer Research May 2022, 42 (5) 2395-2404; DOI: https://doi.org/10.21873/anticanres.15718
  • You have access
    The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases
    CHRISTIAN DOLL, CLAUDIUS STEFFEN, BENEDICTA BECK-BROICHSITTER, MAXIMILIAN RICHTER, KONRAD NEUMANN, ANNE POHRT, PHILIPP LOHNEIS, ANNIKA LEHMANN, MAX HEILAND, CARMEN STROMBERGER, ANNEKATRIN COORDES, KORINNA JOHRENS and JAN-DIRK RAGUSE
    Anticancer Research May 2022, 42 (5) 2405-2413; DOI: https://doi.org/10.21873/anticanres.15719
  • You have access
    Copenhagen Rats Display Dominantly Inherited Yet Non-uniform Resistance to Spontaneous, Radiation-induced, and Chemically-induced Mammary Carcinogenesis
    MAYUMI NISHIMURA, TATSUHIKO IMAOKA, KAZUHIRO DAINO, YUKIKO NISHIMURA, TOSHIAKI KOKUBO, MASARU TAKABATAKE, SHIZUKO KAKINUMA and YOSHIYA SHIMADA
    Anticancer Research May 2022, 42 (5) 2415-2423; DOI: https://doi.org/10.21873/anticanres.15720
  • Open Access
    The Effect of Asparagus Extract on Pancreatic Cancer: An Intriguing Surprise
    HUAPING XIAO, ZULIANG DENG, JACOB T. HOUGH, XUHUI CHEN, ZIWEN ZHU, JACOB LEE, ALDO DOMINGUEZ, TIANRU SHI, JOSEPH SCHMIDT, QIAN BAI, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research May 2022, 42 (5) 2425-2432; DOI: https://doi.org/10.21873/anticanres.15721
  • You have access
    Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance
    YUNMOON OH, JIN-SOL LEE, JI SUN LEE, JAE HYEON PARK, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research May 2022, 42 (5) 2433-2442; DOI: https://doi.org/10.21873/anticanres.15722
  • You have access
    Expression of LncRNAs in HPV-induced Carcinogenesis and Cancer Cachexia: A Study in K14-HPV16 Mice
    TÂNIA R. DIAS, JOANA M. O. SANTOS, DIOGO ESTÊVÃO, NATÁLIA R. COSTA, VERÓNICA F. MESTRE, BEATRIZ MEDEIROS-FONSECA, MARGARIDA M.S.M. BASTOS, PAULA A. OLIVEIRA, RUI M. GIL DA COSTA and RUI MEDEIROS
    Anticancer Research May 2022, 42 (5) 2443-2460; DOI: https://doi.org/10.21873/anticanres.15723
  • You have access
    Changes in Lysophospholipid Components in Ulcerative Colitis and Colitis-associated Cancer
    HIROFUMI SONODA, CHIEKO KITAMURA, KUNIYUKI KANO, HIROYUKI ANZAI, YUZO NAGAI, SHINYA ABE, YUICHIRO YOKOYAMA, HIROAKI ISHII, JUNKO KISHIKAWA, KOJI MURONO, SHIGENOBU EMOTO, KAZUHITO SASAKI, KAZUSHIGE KAWAI, HIROAKI NOZAWA, JUNKEN AOKI and SOICHIRO ISHIHARA
    Anticancer Research May 2022, 42 (5) 2461-2468; DOI: https://doi.org/10.21873/anticanres.15724
  • Open Access
    First Human Cell Experiments With FLASH Carbon Ions
    MUTSUMI TASHIRO, YUKARI YOSHIDA, TAKAHIRO OIKE, MASAO NAKAO, KEN YUSA, YUKA HIROTA and TATSUYA OHNO
    Anticancer Research May 2022, 42 (5) 2469-2477; DOI: https://doi.org/10.21873/anticanres.15725
  • You have access
    Circulating Tumor Cells Derived from Advanced Hepatocellular Carcinoma Rapidly Develop Resistance to Cytotoxic Chemotherapy
    CHIA-HSUN HSIEH, CHAU-TING YEH, YA-HUI HUANG and MING-WEI LAI
    Anticancer Research May 2022, 42 (5) 2479-2486; DOI: https://doi.org/10.21873/anticanres.15726
  • You have access
    Regulation of Expression of Sterol Regulatory Element-binding Protein 1 in Thyroid Cancer Cells
    TUNG-SUN HUANG, JIE-JEN LEE, SHIH-YUAN HUANG and SHIH-PING CHENG
    Anticancer Research May 2022, 42 (5) 2487-2493; DOI: https://doi.org/10.21873/anticanres.15727
  • You have access
    Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib
    CHE-JUI YANG, MENG-HSUAN WU, JAI-JEN TSAI, FEI-TING HSU, TE-CHUN HSIA, KUO-CHING LIU and YU-CHENG KUO
    Anticancer Research May 2022, 42 (5) 2495-2505; DOI: https://doi.org/10.21873/anticanres.15728

Clinical Studies

  • Open Access
    Dynamic Integrated Backscatter Detects Radiotherapy-induced Cardiac Changes Better than Strain Analysis – A Prospective Three-year Study
    SUVI SIRKKU TUOHINEN, TANJA SKYTTA, HEINI HUHTALA, VESA VIRTANEN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and PEKKA RAATIKAINEN
    Anticancer Research May 2022, 42 (5) 2507-2517; DOI: https://doi.org/10.21873/anticanres.15729
  • Open Access
    A Higher Mean Heart Radiation Dose Induces Higher Frequency of Multiple Cardiac Changes
    SUVI SIRKKU TUOHINEN, HANNA AULA, TANJA SKYTTÄ, HEINI HUHTALA, KONSTA KESKI-PUKKILA, KJELL NIKUS, VESA VIRTANEN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and PEKKA RAATIKAINEN
    Anticancer Research May 2022, 42 (5) 2519-2529; DOI: https://doi.org/10.21873/anticanres.15730
  • Open Access
    Poorly Differentiated Thyroid Carcinoma: Single Institution Series of Outcomes
    SIDDHARTH KUNTE, JONATHAN SHARETT, WEI WEI, CHRISTIAN NASR, BRANDON PRENDES, ERIC LAMARRE, JAMIE KU, ROBERT R. LORENZ, JOSEPH SCHARPF, BRIAN B. BURKEY, AKEESHA SHAH, NIKHIL JOSHI and JESSICA L. GEIGER
    Anticancer Research May 2022, 42 (5) 2531-2539; DOI: https://doi.org/10.21873/anticanres.15731
  • You have access
    Prognostic Value of Peritoneal Cancer Index After Complete Cytoreductive Surgery in Advanced Ovarian Cancer
    MIHAELA ASP, SUSANNE MALANDER, JOHAN BENGTSSON, HANNA SARTOR and PAIVI KANNISTO
    Anticancer Research May 2022, 42 (5) 2541-2551; DOI: https://doi.org/10.21873/anticanres.15732
  • Open Access
    Acute Side-effects of Different Radiotherapy Treatment Schedules in Early Prostate Cancer
    PETRI REINIKAINEN, MIKA KAPANEN, TIINA LUUKKAALA and PIRKKO-LIISA KELLOKUMPU-LEHTINEN
    Anticancer Research May 2022, 42 (5) 2553-2565; DOI: https://doi.org/10.21873/anticanres.15733
  • Open Access
    Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease
    YUTARO KUBOTA, QINGHONG HAN, CHIHIRO HOZUMI, NORIYUKI MASAKI, JUN YAMAMOTO, YUSUKE AOKI, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    Anticancer Research May 2022, 42 (5) 2567-2572; DOI: https://doi.org/10.21873/anticanres.15734
  • Open Access
    Surgical Indications for Huge Hepatocellular Carcinoma
    TAKAFUMI KUMAMOTO, RYUSEI MATSUYAMA, KAZUHISA TAKEDA, YU SAWADA, KOTA SAHARA, DAISUKE MORIOKA, SHAO-CIAO LUO, YASUHIRO YABUSHITA, YUKI HOMMA and ITARU ENDO
    Anticancer Research May 2022, 42 (5) 2573-2581; DOI: https://doi.org/10.21873/anticanres.15735
  • Open Access
    Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for EGFR-mutated Non-small Cell Lung Cancer
    TOSHIHIRO SHIOZAWA, TAKESHI NUMATA, TOMOHIRO TAMURA, TAKEO ENDO, TAKAYUKI KABURAGI, YUSUKE YAMAMOTO, HIDEYASU YAMADA, NORIHIRO KIKUCHI, KAZUHITO SAITO, MASAHARU INAGAKI, KOICHI KURISHIMA, YASUNORI FUNAYAMA, KUNIHIKO MIYAZAKI, NOBUYUKI KOYAMA, KINYA FURUKAWA, HIROYUKI NAKAMURA, SHINJI KIKUCHI, HIDEO ICHIMURA, YUKIO SATO, IKUO SEKINE, HIROAKI SATOH and NOBUYUKI HIZAWA
    Anticancer Research May 2022, 42 (5) 2583-2590; DOI: https://doi.org/10.21873/anticanres.15736
  • You have access
    Proton Pump Inhibitors Ameliorate Capecitabine-induced Hand-Foot Syndrome in Patients With Breast Cancer: A Retrospective Study
    MIHO TAKEMURA, KENJI IKEMURA, TETSUHIRO YOSHINAMI, YUJI TOYOZUMI, TAKUYA SHINTANI, MIKIKO UEDA, KENZO SHIMAZU and MASAHIRO OKUDA
    Anticancer Research May 2022, 42 (5) 2591-2598; DOI: https://doi.org/10.21873/anticanres.15737
  • You have access
    p16/Ki-67 Dual Staining Is a Reliable Biomarker for Risk Stratification for Patients With Borderline/Mild Cytology in Cervical Cancer Screening
    MARIA MAGKANA, PANAGIOTA MENTZELOPOULOU, EKATERINI MAGKANA, ANDREAS PAMPANOS, NIKOLAOS VRACHNIS, ELENI KALAFATI, GEORGIOS DASKALAKIS, EKATERINI DOMALI, NIKOLAOS THOMAKOS, ALEXANDROS RODOLAKIS, NICHOLAS P. ANAGNOU and KALLIOPI I. PAPPA
    Anticancer Research May 2022, 42 (5) 2599-2606; DOI: https://doi.org/10.21873/anticanres.15738
  • You have access
    Posterior-Anterior Cephalometric Study of Neurofibromatosis Type 1 Patients With Facial Plexiform Neurofibroma: Analysis of Skeletal Symmetry Concerning Midfacial and Skull Base Reference Points (Zygomatic Arch, Mastoid, and Juga)
    REINHARD E. FRIEDRICH, GEORG CHRIST and HANNA A. SCHEUER
    Anticancer Research May 2022, 42 (5) 2607-2623; DOI: https://doi.org/10.21873/anticanres.15739
  • You have access
    Chemotherapy-induced Reversion of Mutant RAS to Wild-type RAS in Metastatic Colorectal Cancer
    SUMITO SATO, YO MIKAYAMA, MANABU SHIOZAWA, SUGURU NUKADA, KENTA IGUCHI, HIRONAO OKAMOTO, TAKASHI KOHMURA, KEISUKE KAZAMA, KUNIYA TANAKA, TAKASHI OSHIMA and YASUSHI RINO
    Anticancer Research May 2022, 42 (5) 2625-2635; DOI: https://doi.org/10.21873/anticanres.15740
  • You have access
    Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian Cancer
    SHINICHI TATE, KYOKO NISHIKIMI, AYUMU MATSUOKA, SATOYO OTSUKA and MAKIO SHOZU
    Anticancer Research May 2022, 42 (5) 2637-2644; DOI: https://doi.org/10.21873/anticanres.15741
  • You have access
    Impact of Histological Features on Adjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Carcinoma
    TAKAAKI FURUKAWA, MANABU TAKAMATSU, YOSUKE INOUE, TAKESHI OKAMOTO, TAKAFUMI MIE, YUTO YAMADA, TSUYOSHI TAKEDA, AKIYOSHI KASUGA, MASATO MATSUYAMA, TAKASHI SASAKI, MASATO OZAKA, ATSUSHI OBA, HIROMICHI ITO, YOSHIHIRO ONO, TAKAFUMI SATO, YU TAKAHASHI, AKIO SAIURA and NAOKI SASAHIRA
    Anticancer Research May 2022, 42 (5) 2645-2655; DOI: https://doi.org/10.21873/anticanres.15742
  • You have access
    Risk Factors for Xerostomia Following Radiotherapy of Head-and-Neck Cancers
    BRITTA WARWAS, FLORIAN CREMERS, KARSTEN GERULL, ANKE LEICHTLE, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research May 2022, 42 (5) 2657-2663; DOI: https://doi.org/10.21873/anticanres.15743
  • You have access
    Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma
    MICHAEL H. WANG, WILSON ROA, KEITH WACHOWICZ, ATIYAH YAHYA, ALBERT MURTHA, JOHN AMANIE, JONATHAN CHAINEY, HARVEY QUON, SUNITA GHOSH and SAMIR PATEL
    Anticancer Research May 2022, 42 (5) 2665-2673; DOI: https://doi.org/10.21873/anticanres.15744
  • You have access
    Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen
    HIROAKI TANIOKA, KEN SHIMADA, AKIHITO TSUJI, MITSUGU KOCHI, HO MIN KIM, TAKAO TAKAHASHI, TADAMICHI DENDA, AKINORI TAKAGANE, TAKANORI WATANABE, MASAHITO KOTAKA, MASATO NAKAMURA, YU SUNAKAWA, MASAHIRO TAKEUCHI, WATARU ICHIKAWA and MASASHI FUJII
    Anticancer Research May 2022, 42 (5) 2675-2681; DOI: https://doi.org/10.21873/anticanres.15745
  • Open Access
    Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial
    KEISHO CHIN, DAISUKE TAKAHARI, RYOHEI KAWABATA, HISASHI HOSAKA, SO SAITOU, TAKESHI SHIRAISHI, HIROSHI YABUSAKI, MASAHIRO GOTO, MASATO NAKAMURA, HIROSHI IMAMURA, YOSHIAKI SHINDO, FUMIO NAGASHIMA, WATARU ICHIKAWA, TAKASHI SAOTOME, WATARU YAMAMOTO, NAOKI ISHIZUKA and KENSEI YAMAGUCHI
    Anticancer Research May 2022, 42 (5) 2683-2687; DOI: https://doi.org/10.21873/anticanres.15746
  • You have access
    Association Between PD-L1 and Histatin1, 3 Expression in Advanced Head and Neck Squamous Cell Carcinoma
    WASSAPOL WONGPANUWICH, SOMCHAI YODSANGA, RISA CHAISUPARAT and PANOMWAT AMORNPHIMOLTHAM
    Anticancer Research May 2022, 42 (5) 2689-2699; DOI: https://doi.org/10.21873/anticanres.15747
  • You have access
    Repeated Stereotactic Body Radiotherapy for Lung Malignancies: Toxicity Can Be Reduced by Sparing Lung Irradiation
    SHOU WATANABE, HIDEYA YAMAZAKI, TAKYUA KIMOTO, GEN SUZUKI and KEI YAMADA
    Anticancer Research May 2022, 42 (5) 2701-2709; DOI: https://doi.org/10.21873/anticanres.15748
  • You have access
    The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment
    TORU AOYAMA, MIHWA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, ITARU HASHIMOTO, KAZUKI KANO, KENTARO HARA, HARUHIKO CHO, KENKI SEGAMI, DAISUKE MACHIDA, MASATO NAKAZONO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research May 2022, 42 (5) 2711-2717; DOI: https://doi.org/10.21873/anticanres.15749
  • You have access
    Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective Study
    KEISUKE KOMORI, KAZUKI KANO, TAKANOBU YAMADA, HAYATO WATANABE, KOSUKE TAKAHASHI, YUKIO MAEZAWA, HIROHITO FUJIKAWA, MASAKATSU NUMATA, TORU AOYAMA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, TAKASHI OGATA and TAKASHI OSHIMA
    Anticancer Research May 2022, 42 (5) 2719-2725; DOI: https://doi.org/10.21873/anticanres.15750
  • You have access
    Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma
    SUGURU SHIROTAKE, YU MIYAMA, YASUTAKA BABA, HIROYUKI TAJIMA, YOSHITAKA OKADA, KEN NAKAZAWA, YOKO USAMI, MASANORI YASUDA, DAISUKE IGARASHI, GO KANEKO, KENT KANAO, MASAFUMI OYAMA and KOSHIRO NISHIMOTO
    Anticancer Research May 2022, 42 (5) 2727-2735; DOI: https://doi.org/10.21873/anticanres.15751
  • You have access
    Time to Onset of Bendamustine-associated Skin Damage Using the Spontaneous Reporting System
    MISUI KASHIWAGI, TADASHI SHIMIZU, RIKA KAWAI, TAKEHIRO KAWASHIRI, YOSHIHIRO UESAWA and MAYAKO UCHIDA
    Anticancer Research May 2022, 42 (5) 2737-2741; DOI: https://doi.org/10.21873/anticanres.15752
  • You have access
    Diversified Effects of Bile Contamination, Postoperative Infections, and Antimicrobial Resistance Level on the Oncologic Prognosis After Pancreatoduodenectomy for Ductal Adenocarcinoma
    LUCA GIANOTTI, KIM C. HONSELMANN, MARCO ANGRISANI, FRANCESCA GAVAZZI, TOBIAS KECK, ULRICH WELLNER, LOUISA BOLM, NATALIE PETRUCH, GIOVANNI CAPRETTI, GENNARO NAPPO, DAVIDE P. BERNASCONI, MARTA SANDINI and ALESSANDRO ZERBI
    Anticancer Research May 2022, 42 (5) 2743-2752; DOI: https://doi.org/10.21873/anticanres.15753
  • You have access
    High Receptor-interacting Serine/Threonine-protein Kinase 3 (RIP3) Expression Serves as an Independent Poor Prognostic Factor for Triple-negative Breast Carcinoma
    YUMIN CHUNG, SINAE KIM, HYUN-SOO KIM and SUNG-IM DO
    Anticancer Research May 2022, 42 (5) 2753-2761; DOI: https://doi.org/10.21873/anticanres.15754
  • You have access
    Impact of Infectious Complications on Survival and Recurrence of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective Study
    HIROSHI TAMAGAWA, TORU AOYAMA, MASAKATSU NUMATA, KEISUKE KAZAMA, YOSUKE ATSUMI, KENTA IGUCHI, MIHWA JU, SHO SAWAZAKI, SUMITO SATO, KAZUKI KANO, TAKASHI OHSHIMA, TAKANOBU YAMADA, TENI GODAI, AKIO HIGUCHI, HIROYUKI SAEKI, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research May 2022, 42 (5) 2763-2769; DOI: https://doi.org/10.21873/anticanres.15755
  • You have access
    Handgrip Strength Predicts Poorly the Surgical Outcome or Length of Hospitalization in Patients With Surgically Operated Oral Cancer
    JUHO SUOJANEN, SATU KAINULAINEN, LAURA TARVAINEN, JYRKI TORNWALL and TOMMY WILKMAN
    Anticancer Research May 2022, 42 (5) 2771-2774; DOI: https://doi.org/10.21873/anticanres.15756
  • You have access
    Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma
    TAKASHI KATO, TARO OSHIKIRI, HIRONOBU GOTO, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, TAKERU MATSUDA and YOSHIHIRO KAKEJI
    Anticancer Research May 2022, 42 (5) 2775-2782; DOI: https://doi.org/10.21873/anticanres.15757
  • You have access
    Usefulness of Prophylactic Administration of Pegfilgrastim for Esophageal Cancer Chemotherapy: A Single-center Retrospective Study
    KOICHI OKAMOTO, ITASU NINOMIYA, HIROTO SAITO, MARI SHIMADA, TAKAHISA YAMAGUCHI, SHIRO TERAI, HIDEKI MORIYAMA, JUN KINOSHITA, KEISHI NAKAMURA and NORIYUKI INAKI
    Anticancer Research May 2022, 42 (5) 2783-2790; DOI: https://doi.org/10.21873/anticanres.15758
  • You have access
    Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
    MANABU EMI, YOICHI HMAI, TORU YOSHIKAWA, RYOSUKE HIROHATA, MANATO OSAWA, MORIHITO OKADA, YUJI MURAKAMI and IKUNO NISHIBUCHI
    Anticancer Research May 2022, 42 (5) 2791-2795; DOI: https://doi.org/10.21873/anticanres.15759
  • You have access
    Prognostic Value of the Regional Lymph Node Station in Pancreatic Neuroendocrine Tumor
    KOSEI TAKAGI, YUZO UMEDA, RYUICHI YOSHIDA, KAZUHIRO YOSHIDA, TOMOKAZU FUJI, KENJIRO KUMANO, KAZUYA YASUI, TAKAHITO YAGI and TOSHIYOSHI FUJIWARA
    Anticancer Research May 2022, 42 (5) 2797-2801; DOI: https://doi.org/10.21873/anticanres.15760

Corrigendum

  • Open Access
    Corrigendum
    Anticancer Research May 2022, 42 (5) 2803;
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (5)
Anticancer Research
Vol. 42, Issue 5
May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • A Higher Mean Heart Radiation Dose Induces Higher Frequency of Multiple Cardiac Changes
  • Dimethyl Fumarate Induces Apoptosis via Inhibiting NF-κB and STAT3 Signaling in Adult T-cell Leukemia/Lymphoma Cells
  • Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer
  • Acute Side-effects of Different Radiotherapy Treatment Schedules in Early Prostate Cancer
  • The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Corrigendum
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire